Journal of the American Society of Echocardiography
Volume 23, Issue 8 , Pages 848-853 , August 2010

Exercise-Induced Left Ventricular Systolic Dysfunction in Women Heterozygous for Dystrophinopathy

  • Robert M. Weiss, MD

      Affiliations

    • Division of Cardiovascular Medicine, University of Iowa, Iowa City, Iowa
    • Corresponding Author InformationReprint requests: Robert M. Weiss, MD, University of Iowa Hospitals and Clinics, Division of Cardiovascular Medicine, Department of Internal Medicine, 200 Hawkins Drive, Room E317-1 GH, Iowa City, IA 52242.
  • ,
  • Richard E. Kerber, MD, FASE

      Affiliations

    • Division of Cardiovascular Medicine, University of Iowa, Iowa City, Iowa
  • ,
  • Jane K. Jones, RDCS, FASE

      Affiliations

    • Division of Cardiovascular Medicine, University of Iowa, Iowa City, Iowa
  • ,
  • Carrie M. Stephan, BSN, MA

      Affiliations

    • Department of Pediatrics, University of Iowa, Iowa City, Iowa
  • ,
  • Christina J. Trout, MSN

      Affiliations

    • Department of Pediatrics, University of Iowa, Iowa City, Iowa
  • ,
  • Paul D. Lindower, MD, FASE

      Affiliations

    • Division of Cardiovascular Medicine, University of Iowa, Iowa City, Iowa
  • ,
  • Kimberly S. Staffey, MD

      Affiliations

    • Division of Cardiovascular Medicine, University of Iowa, Iowa City, Iowa
  • ,
  • Kevin P. Campbell, PhD

      Affiliations

    • Division of Cardiovascular Medicine, University of Iowa, Iowa City, Iowa
    • Department of Neurology, University of Iowa, Iowa City, Iowa
    • Department of Molecular Physiology and Biophysics, University of Iowa, Iowa City, Iowa
    • Carver College of Medicine, and the Howard Hughes Medical Institute, University of Iowa, Iowa City, Iowa
  • ,
  • Katherine D. Mathews, MD

      Affiliations

    • Department of Pediatrics, University of Iowa, Iowa City, Iowa

References 

  1. Emery AE. The muscular dystrophies. Lancet. 2002;359:687–695
  2. Ortiz-Lopez R, Li H, Su J, Goytia V, Towbin JA. Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation. 1997;95:2434–2440
  3. Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, et al. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med. 1999;5:320–326
  4. McMahon CJ, Vatta M, Fraser CD, Towbin JA, Chang AC. Altered dystrophin expression in the right atrium of a patient after Fontan procedure with atrial flutter. Heart. 2004;90:e65
  5. Vatta M, Stetson SJ, Jimenez S, Entman ML, Noon GP, Bowles NE, et al. Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices. J Am Coll Cardiol. 2004;43:811–817
  6. Politano L, Nigro V, Nigro G, Petretta VR, Passamano L, Papparella S, et al. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA. 1996;275:1335–1338
  7. Cripe LH for the American Academy of Pediatrics Section on Cardiology and Cardiac Surgery. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics. 2005;116:1569–1573
  8. Kamogawa Y, Biro S, Maeda M, Setoguchi M, Hirakawa T, Yoshida H, et al. Dystrophin-deficient myocardium is vulnerable to pressure overload in vivo. Cardiovasc Res. 2001;50:509–515
  9. Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation. 2001;104:1694–40
  10. Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, Manning WJ, et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr. 2004;17:1086–1119
  11. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539–542
  12. Otto CM. Ischemic cardiac disease. In:  Otto CM editors. Textbook of clinical echocardiography. Philadelphia: Elsevier Saunders; 2004;p. 196–224
  13. Glantz SA. Primer of Biostatistics version 4.02 for Windows, 1996.
  14. Chen J, Chien KR. Complexity in simplicity: monogenic disorders and complex cardiomyopathies. J Clin Invest. 1999;103:1483–1485
  15. Nagueh SF, McFalls J, Meyer D, Hill R, Zoghbi WA, Tam JW, et al. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation. 2003;108:395–398
  16. Holloway SM, Wilcox DE, Wilcox A, Dean JC, Berg JN, Goudie DR, et al. Life expectancy and death from cardiomyopathy amongst carriers of Duchenne and Becker muscular dystrophy in Scotland. Heart. 2008;94:633–636
  17. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. J Am Coll Cardiol. 2005;46:1116–1143
  18. The SOLVD Investigators . Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685–691
  19. Fleg JL, Piña IL, Balady GJ, Chaitman BR, Fletcher B, Lavie C, et al. Assessment of functional capacity in clinical and research applications. An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. Circulation. 2000;102:1591
  20. Green P, Lund LH, Mancini D. Comparison of peak exercise oxygen consumption and the heart failure survival score for predicting prognosis in women versus men. Am J Cardiol. 2007;99:399–403
  21. Roger VL, Pellikka PA, Bell MR, Chow CWH, Bailey KR, Seward JB. Sex and test verification bias. Impact on the diagnostic value of exercise echocardiography. Circulation. 1997;95:405–410
  22. Shen WF, Roubin GS, Hirasawa K, Choong CY, Hutton BF, Harris PJ, et al. Left ventricular volume and ejection fraction response to exercise in chronic congestive heart failure: difference between dilated cardiomyopathy and previous myocardial infarction. Am J Cardiol. 1985;55:1027
  23. Duncan AM, Francis PF, Gibson DG, Henein MY. Differentiation of ischemic from nonischemic cardiomyopathy during dobutamine stress by left ventricular long-axis function. Circulation. 2003;108:1214–1220
  24. Limacher MC, Quinones MA, Poliner LR, Nelson JG, Winters WL, Waggoner AD. Detection of coronary artery disease with exercise two-dimensional echocardiography. Description of a clinically applicable method and comparison with radionuclide ventriculography. Circulation. 1983;67:1211–1218
  25. Migeon BR. The role of X inactivation and cellular mosaicism in women's health and sex-specific diseases. JAMA. 2006;295:1428–1433
  26. Hoogerwaard EM, Bakker E, Ippel PF, Oosterwijk JC, Majoor-Krakauer DF, Leschot NJ, et al. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in the Netherlands: a cohort study. Lancet. 1999;353:2116–2119
  27. Coral-Vasquez R, Cohn RD, Moore SA, Hill JA, Weiss RM, Davisson RL, et al. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell. 1999;98:465–474
  28. Wheeler MT, Allikian MJ, Heydemann A, Hadhazy M, Zarnegar S, McNally EM. Smooth muscle cell-extrinsic vascular spasm arises from cardiomyocyte degeneration in sarcoglycan-deficient cardiomyopathy. J Clin Invest. 2004;113:668–675
  29. Sander M, Chavoshan B, Harris SA, Iannaccone ST, Stull JT, Thomas GD, et al. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci U S A. 2000;97:13818–13823
  30. Shaw LJ, Merz CN, Pepine CJ, Reis SE, Bittner V, Kip KE, et al. for the Women's Ischemia Syndrome Evaluation (WISE) Investigators The economic burden of angina in women with suspected ischemic heart disease: results from the NIH-NHLBI–sponsored Women's Ischemia Syndrome Evaluation. Circulation. 2006;114:894–904
  31. Azofeifa J, Voit T, Hubner C, Cremer M. X-chromosome methylation in manifesting and healthy carriers of dystrophinopathies: concordance of activation ratios among first degree female relatives and skewed inactivation as cause of the affected phenotypes. Hum Genet. 1995;96:167–176
  32. Carasso S, Yang H, Woo A, Jamorski M, Wigle ED, Rakowski H. Diastolic myocardial mechanics in hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2010;23:164–171
  33. Van Dalen BM, Kauer F, Michels M, Soliman OI, Vletter WB, van der Zwaan HB, et al. Delayed left ventricular untwisting in hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2009;22:1320–1326
  34. Di Cori A, Bongiorni MG, Zucchelli G, Soldati E, Falorni M, Segreti L, et al. Early left ventricular structural myocardial alterations and their relationship with functional and electrical properties of the heart in myotonic dystrophy type 1. J Am Soc Echocardiogr. 2009;22:1173–1179

 This work was supported by a research grant from the Muscular Dystrophy Association (Tucson, AZ) and by a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant from the National Institutes of Health (Bethesda, MD). Dr Campbell is an investigator of the Howard Hughes Medical Institute (Chevy Chase, MD).

PII: S0894-7317(10)00419-0

doi: 10.1016/j.echo.2010.05.007

Journal of the American Society of Echocardiography
Volume 23, Issue 8 , Pages 848-853 , August 2010